Scientific publications 

Treatment of supratentorial glioma with intracarotid cisplatin and intravenous carmustine

Rebollo J., Martín-Algarra S., Bilbao I., Zubieta J.L. [SP], Calvo F.A., de Castro P., Pastor M.A., [SP] Viteri C. [SP], Martínez Lage J.M.
Departamentos de Oncología Médica, Clínica Universitaria de Navarra, Pamplona.

Magazine: Neurologia

Date: Aug 1, 1990

Radiology [SP] Neurology [SP] Medical Oncology

We report the results of intracarotid (IC) cisplatinum and intravenous carmustine (BCNU) in 26 patients with supratentorial malignant glioma and recurrent low grade glioma. A response rate of 53.84% (95% confidence interval 33.3%-73.4%) was found.

The median survival for the whole group was 11 months (range 3-70), with 35% of patients surviving for 2 years. At the present time, 5 patients are still alive, with a median follow up of 68 months (range 56-70).

Neurological toxicity has been low and transient, being attributable to the technical degree of care in catheter positioning, cisplatin dosage and the technique of drug administration into the carotid artery.

CITATION  Neurologia. 1990 Aug-Sep;5(7):228-32

you maybe interested


The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra


The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra


Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra